These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 30326899)

  • 1. Recent advancements in the use of exosomes as drug delivery systems.
    Bunggulawa EJ; Wang W; Yin T; Wang N; Durkan C; Wang Y; Wang G
    J Nanobiotechnology; 2018 Oct; 16(1):81. PubMed ID: 30326899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
    Ramesh D; Bakkannavar S; Bhat VR; Sharan K
    F1000Res; 2023; 12():329. PubMed ID: 37868300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Exosome Isolation and Analysis in Health and Disease.
    Ludwig N; Whiteside TL; Reichert TE
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
    Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
    Cells; 2023 May; 12(10):. PubMed ID: 37408250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the development and establishment of exosome-based drug delivery systems.
    Wang J; Chen D; Ho EA
    J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of plant-derived exosome-like nanoparticles in drug delivery.
    Barzin M; Bagheri AM; Ohadi M; Abhaji AM; Salarpour S; Dehghannoudeh G
    Pharm Dev Technol; 2023 Jun; 28(5):383-402. PubMed ID: 37086283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
    Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
    Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems.
    Ohno S; Drummen GP; Kuroda M
    Int J Mol Sci; 2016 Feb; 17(2):172. PubMed ID: 26861303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress of exosomes as drug carriers in cancer and inflammation.
    Feng Q; Zhang Y; Fang Y; Kong X; He Z; Ji J; Yang X; Zhai G
    J Drug Target; 2023 Apr; 31(4):335-353. PubMed ID: 36543743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-Based Treatment for Atherosclerosis.
    Heo J; Kang H
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.